Institution
The University of Texas MD Anderson Cancer Center
- 410running trials
- 191closed trials
- 11researchers
- 177,833publications (OpenAlex)
Researchers
Running trials
Not yet recruiting
Recruiting
Recruiting
A Phase I Clinical Study of YN003 in the Treatment of Glioma
Recruiting
Recruiting
TMV Vaccine Alone or With Toripalimab-tpzi for Recurrent Head and Neck Squamous Cell Carcinoma
Recruiting
Recruiting
Not yet recruiting
A Study of AL58805 in Advanced, Metastatic GYN, STS or Breast Cancers
Not yet recruiting
A Study of Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM Cancers
Recruiting
Enrolling by invitation
Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study
Recruiting
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
Recruiting
Recruiting
AQUA07 in Patients With ALK-Positive Non-Small Cell Lung Cancer
Recruiting
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
Recruiting
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Showing 50 of 410.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer76 recruiting
- Colorectal cancer36 recruiting
- Pancreatic cancer30 recruiting
- Gastric and oesophageal cancer25 recruiting
- Childhood cancers23 recruiting
- Melanoma22 recruiting
- Ovarian cancer22 recruiting
- Prostate cancer21 recruiting
- Endometrial cancer20 recruiting
- Head and neck cancer19 recruiting
- Sarcoma18 recruiting
- Bladder cancer17 recruiting
- Acute myeloid leukaemia15 recruiting
- Liver and biliary tract cancer15 recruiting
- Metastatic breast cancer15 recruiting
- Triple-negative breast cancer14 recruiting
- Kidney cancer13 recruiting
- Myelodysplastic syndromes12 recruiting
- Cervical cancer10 recruiting
- Multiple myeloma8 recruiting
- Chronic myeloid leukaemia7 recruiting
- Glioblastoma7 recruiting
- Neuroendocrine tumours7 recruiting
- Chronic lymphocytic leukaemia6 recruiting
- Myeloproliferative neoplasms6 recruiting
- Acute lymphoblastic leukaemia5 recruiting
- Mesothelioma5 recruiting
- Diffuse large B-cell lymphoma4 recruiting
- Follicular lymphoma4 recruiting
- Brain metastases3 recruiting
- Mantle cell lymphoma3 recruiting
- Thyroid cancer3 recruiting
- Burkitt lymphoma2 recruiting
- Deep vein thrombosis and pulmonary embolism2 recruiting
- Barrett's oesophagus1 recruiting
- Chronic kidney disease1 recruiting
- Cytomegalovirus infection1 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Haemophagocytic lymphohistiocytosis1 recruiting
- Hidradenitis suppurativa1 recruiting
- HIV1 recruiting
- Lupus (SLE)1 recruiting
- Myasthenia gravis1 recruiting
- Neuroblastoma1 recruiting
- Rheumatoid arthritis1 recruiting
Closed trials
Withdrawn
Completed
Terminated
Terminated
Terminated
Terminated
Terminated
Terminated
Completed
Terminated
Terminated
Terminated
Completed
Phase 2B Safety and Efficacy Study of VGT-309 in Subjects With Cancer in the Lung.
Completed
Completed
Completed
Terminated
A Clinical Study of ONCT-808 in Subjects With Relapsed or Refractory B-Cell Malignancies
Completed
Completed
Completed
Terminated
ZN-c3 in Adult Participants With Metastatic Colorectal Cancer
Terminated
Completed
Terminated
A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors
Terminated
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Completed
Completed
ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies
Terminated
A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma
Terminated
Completed
Completed
Completed
Terminated
Study of the ZN-d5 and ZN-c3 in Subjects With Acute Myeloid Leukemia (AML)
Completed
Terminated
AMG 176 With Azacitidine in Subjects With Myelodysplastic Syndrome /Chronic Myelomonocytic Leukemia
Completed
MicroOrganoSphere (MOS) Drug Screen Pilot Trial in Colorectal Cancer
Terminated
Terminated
Completed
Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
Terminated
Completed
Completed
Terminated
Withdrawn
Completed
Completed
Completed
A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling
Terminated
Terminated
Terminated
A Study of Dual-SIgnaling Protein 107 (DSP107) for Patients With Hematological Malignancies
Showing 50 of 191.
Registry name variants (61)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
The University of Texas MD Anderson Cancer Center
Houston, Texas 77030
276 trials
University of Texas - MD Anderson Cancer Center
Houston, Texas 77030
258 trials
MD Anderson Cancer Center - University of Texas
Houston, Texas 77030
9 trials
The University of Texas, MD Anderson Cancer Center - West Houston
Houston, Texas 77079
6 trials
The University of Texas MD Anderson Cancer Center (Site 0009)
Houston, Texas 77030
4 trials
The University of Texas MD Anderson Cancer Centre
Houston, Texas 77030
4 trials
University of Texas -MD Anderson Cancer Center, 1515 Holcombe Blvd.
Houston, Texas 77030
2 trials
Contact: Priti Tewari, MD (principal investigator)
~University of Texas - MD Anderson Cancer Center Site Number : 8400002
Houston, Texas 77030
2 trials
MD Anderson Cancer Center The University of Texas
Houston, Texas 77030
1 trial
MD Anderson Cancer Center/University of Texas MD Anderson
Houston, Texas 77030
1 trial
The University of Texas MD Anderson Cancer Center
Texas City, Texas 77030
1 trial
Contact: Maria Pia Morelli, MD (principal investigator)
The University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology
Houston, Texas 77030
1 trial
The University of Texas MD Anderson Cancer Center, Department of Leukemia
Houston, Texas 77030
1 trial
The University of Texas - MD Anderson Cancer Center - Genitourinary (GU) Cancer Center
Houston, Texas 77030-4004
1 trial
The University of Texas MD Anderson Cancer Center, Gynecologic Oncology Center
Houston, Texas 77030
1 trial
NCT06730347A Study of Lorigerlimab in Participants With Advanced Solid Tumors
Contact: Mariana Gallardo
The University of Texas MD Anderson Cancer Center
Houston, Texas 77030
1 trial
The University of Texas MD Anderson Cancer Center
Houston, Texas 77030
1 trial
The University of Texas MD Anderson Cancer Center
Houston, Texas 77030
1 trial
The University of Texas MD Anderson Cancer Center
Houston, Texas 77030
1 trial
The University of Texas MD Anderson Cancer Center
Houston, Texas 77030
1 trial
The University of Texas MD Anderson Cancer Center
Houston, Texas 77030
1 trial
The University of Texas MD Anderson Cancer Center
Houston, Texas 77030
1 trial
The University of Texas MD Anderson Cancer Center
Houston, Texas 77030
1 trial
The University of Texas MD Anderson Cancer Center
Houston, Texas 77030
1 trial
The University of Texas - MD Anderson Cancer Center - Infectious Diseases
Houston, Texas 77030-4000
1 trial
The University of Texas-MD Anderson Cancer Center - Leukemia Center
Houston, Texas 77030
1 trial
Contact: Guillermo Garcia-Manero (principal investigator)
The University of Texas MD Anderson Cancer Center Site #102
Houston, Texas 77030
1 trial
The University of Texas MD Anderson Cancer Center (site 127)
Houston, Texas 77030
1 trial
Contact: Madison Maas
The University of Texas MD Anderson Cancer Center- Site Number : 8400008
Houston, Texas 77030
1 trial
The University of Texas of MD Anderson Cancer Center
Houston, Texas 77030
1 trial
University of Texas MD Anderson Cancer Center,1155 Pressler St
Houston, Texas 77030
1 trial
University of Texas MD Anderson Cancer Center - Accepting Adult Patients
Houston, Texas 77030
1 trial
Contact: Christina Amos Briggs, BSN, RN
University of Texas MD Anderson Cancer Center
Houston, Texas 77030
1 trial
University of Texas MD Anderson Cancer Center
Houston, Texas 77030
1 trial
University of Texas MD Anderson Cancer Center
Houston, Texas 77030
1 trial
University of Texas MD Anderson Cancer Center
Houston, Texas 77030
1 trial
University of Texas MD Anderson Cancer Center
Houston, Texas 77030
1 trial
University of Texas MD Anderson Cancer Center
Houston, Texas 77030
1 trial
University of Texas MD Anderson Cancer Center
Houston, Texas 77030
1 trial
University of Texas MD Anderson Cancer Center
Houston, Texas 77030
1 trial
University of Texas MD Anderson Cancer Center
Houston, Texas 77030
1 trial
University of Texas MD Anderson Cancer Center
Houston, Texas 77030
1 trial
NCT04777994Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Contact: Site Coordinator
University of Texas MD Anderson Cancer Center
Houston, Texas 77030
1 trial
University of Texas MD Anderson Cancer Center (Site 0001)
Houston, Texas 77030
1 trial
University of Texas MD Anderson Cancer Center (Site 0004)
Houston, Texas 77030
1 trial
University of Texas MD Anderson Cancer Center (Site 0026)
Houston, Texas 77030
1 trial
University of Texas-MD Anderson Cancer Center (Site 0055)
Houston, Texas 77030
1 trial
Contact: Study Coordinator
University of Texas MD Anderson Cancer Center (Site 0112)
Houston, Texas 77030
1 trial
Contact: Study Coordinator
University of Texas-MD Anderson Cancer Center (Site 0134)
Houston, Texas 77030
1 trial
University of Texas MD Anderson Cancer Center (Site 0316)
Houston, Texas 77030
1 trial
Contact: Study Coordinator
University of Texas MD Anderson Cancer Center (Site 1006)
Houston, Texas 77030
1 trial
University of Texas MD Anderson Cancer Center (Site 1007)
Houston, Texas 77030
1 trial
University of Texas-MD Anderson Cancer Center (Site 1323)
Houston, Texas 77030
1 trial
NCT07634471A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Contact: Study Coordinator
University of Texas MD Anderson Cancer Center (Site 1920)
Houston, Texas 77030
1 trial
University of Texas-MD Anderson Cancer Center (Site 3007)
Houston, Texas 77030
1 trial
Contact: Study Coordinator
University of Texas-MD Anderson Cancer Center (Site 3283)
Houston, Texas 77030
1 trial
University of Texas MD Anderson Cancer Center (Site 6920)
Houston, Texas 77030
1 trial
University of Texas MD Anderson Cancer Center (Site 8920)
Houston, Texas 77030
1 trial
Contact: Study Coordinator
University of Texas MD Anderson Cancer Center - Unit 432 Thoracic Head and Neck Medical Oncology
Houston, Texas 77030
1 trial
University Of Texas Md Anderson Cancer Ctr
Houston, Texas 77030-4009
1 trial
Univ of Texas MD Anderson Cancer Center, Division of Cancer Medicine
Houston, Texas 77030
1 trial
Contact: Guillermo Garcia-Manero (principal investigator)
Conditions
Diseases this institution publishes on or runs trials for.
- Lung cancer544 works · 169 trials
- Melanoma289 works · 59 trials
- Colorectal cancer279 works · 86 trials
- Prostate cancer242 works · 42 trials
- Acute myeloid leukaemia222 works · 49 trials
- Liver and biliary tract cancer220 works · 37 trials
- Sarcoma189 works · 37 trials
- Pancreatic cancer181 works · 61 trials
- Ovarian cancer158 works · 57 trials
- Glioblastoma148 works · 19 trials
- Kidney cancer134 works · 27 trials
- Bladder cancer133 works · 34 trials
- Multiple myeloma129 works · 24 trials
- Brain metastases125 works · 5 trials
- Triple-negative breast cancer119 works · 35 trials
- Head and neck cancer107 works · 62 trials
- Cervical cancer102 works · 19 trials
- Gastric and oesophageal cancer101 works · 50 trials
- Metastatic breast cancer95 works · 25 trials
- Acute lymphoblastic leukaemia87 works · 16 trials
- Hodgkin lymphoma83 works · 7 trials
- Myelodysplastic syndromes78 works · 27 trials
- Myeloproliferative neoplasms66 works · 18 trials
- Neuroendocrine tumours57 works · 13 trials
- Chronic lymphocytic leukaemia57 works · 24 trials
- Endometrial cancer51 works · 42 trials
- Diffuse large B-cell lymphoma51 works · 15 trials
- Chronic myeloid leukaemia51 works · 18 trials
- Mantle cell lymphoma50 works · 14 trials
- Follicular lymphoma50 works · 14 trials
Institution data: ROR 04twxam07 (CC0-1.0)Updated 15 Nov 2026